Overexpression of salusin-β is associated with poor prognosis in ovarian cancer

  • Authors:
    • Qian Zhang
    • Wen-Ming Chen
    • Xin-Xin Zhang
    • Hu-Xiang Zhang
    • Han-Chu Wang
    • Fei-Yun Zheng
    • Fang-Fang Zhu
  • View Affiliations

  • Published online on: February 7, 2017     https://doi.org/10.3892/or.2017.5429
  • Pages: 1826-1832
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ovarian cancer is recognized as one of the worst gynecologic malignancies associated with rapid metastasis and poor overall survival rate. The identified valuable molecular biomarkers criticize importance of timely diagnosis for ovarian cancer. Salusin-β levels are dramatically increased in women with polycystic ovarian syndrome. However, the roles of salusin-β in ovarian cancer have yet to be fully elucidated. A total of 57 paired ovarian cancer specimens and matched adjacent normal tissues were used to measure the salusin-β levels. The prognostic value of salusin-β for tumor progression and survival rate was investigated. The effects of salusin-β on ovarian cancer cell proliferation and epithelial-mesenchymal transition were also explored. The expression of salusin-β was significantly increased in ovarian cancer tissue specimens compared with matched normal adjacent tissue (P<0.05). The high salusin-β level was closely related with FIGO stage and lymph node metastases. The ovarian cancer patients with high salusin-β had a shorter overall survival (P<0.05). Salusin-β obviously enhanced the proliferation and epithelial mesenchymal-transition of SKOV3 cells. Furthermore, salusin-β substantially decreased the expression of p-GSK-3β and GSK-3β, but stimulated the β-catenin expression and downstream genes of wnt/β-catenin including cyclin D1 and C-myc. Our data demonstrated for the first time that upregulated salusin-β may be a novel independent prognostic biomarker for overall survival of ovarian cancer. Salusin-β accelerated the proliferation and epithelial mesenchymal transition of ovarian cancer cells at least partly via activation of Wnt/β-catenin signaling pathway. Salusin-β may be an important target for therapeutic intervention in ovarian cancer.
View Figures
View References

Related Articles

Journal Cover

March-2017
Volume 37 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q, Chen W, Zhang X, Zhang H, Wang H, Zheng F and Zhu F: Overexpression of salusin-β is associated with poor prognosis in ovarian cancer. Oncol Rep 37: 1826-1832, 2017
APA
Zhang, Q., Chen, W., Zhang, X., Zhang, H., Wang, H., Zheng, F., & Zhu, F. (2017). Overexpression of salusin-β is associated with poor prognosis in ovarian cancer. Oncology Reports, 37, 1826-1832. https://doi.org/10.3892/or.2017.5429
MLA
Zhang, Q., Chen, W., Zhang, X., Zhang, H., Wang, H., Zheng, F., Zhu, F."Overexpression of salusin-β is associated with poor prognosis in ovarian cancer". Oncology Reports 37.3 (2017): 1826-1832.
Chicago
Zhang, Q., Chen, W., Zhang, X., Zhang, H., Wang, H., Zheng, F., Zhu, F."Overexpression of salusin-β is associated with poor prognosis in ovarian cancer". Oncology Reports 37, no. 3 (2017): 1826-1832. https://doi.org/10.3892/or.2017.5429